相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Expression of SAA1, SAA2 and SAA4 genes in human primary monocytes and monocyte-derived macrophages
Claire Jumeau et al.
PLOS ONE (2019)
Identification of key genes and upstream regulators in ischemic stroke
Qian Zhang et al.
BRAIN AND BEHAVIOR (2019)
Cholesterol Mass Efflux Capacity, Incident Cardiovascular Disease, and Progression of Carotid Plaque The Multi-Ethnic Study of Atherosclerosis
Steven Shea et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2019)
Shotgun proteomic analysis reveals proteome alterations in HDL of patients with cholesteryl ester transfer protein deficiency
Takeshi Okada et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2019)
Genetic control of the mouse HDL proteome defines HDL traits, function, and heterogeneity
Nathalie Pamir et al.
JOURNAL OF LIPID RESEARCH (2019)
High-density lipoprotein (HDL) metabolism and bone mass
Nicholaos I. Papachristou et al.
JOURNAL OF ENDOCRINOLOGY (2017)
Utility of Items of Baseline National Institutes of Health Stroke Scale as Predictors of Functional Outcomes at Three Months after Mild Ischemic Stroke
Jay Chol Choi et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2017)
Utility of Items of Baseline National Institutes of Health Stroke Scale as Predictors of Functional Outcomes at Three Months after Mild Ischemic Stroke
Jay Chol Choi et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2017)
Stroke-associated pattern of gene expression previously identified by machine-learning is diagnostically robust in an independent patient population
Grant C. O'Connell et al.
GENOMICS DATA (2017)
HDL-ASSOCIATED SERUM AMYLOID A (SAA) MAY BE A PREDICTOR OF CARDIOVASCULAR RISK INDEPENDENT OF HDL- OR LDL-CHOLESTEROL
Tomas Vaisar et al.
ATHEROSCLEROSIS (2017)
Plasminogen promotes cholesterol efflux by the ABCA1 pathway
Nathalie Pamir et al.
JCI INSIGHT (2017)
High density lipoproteins are modulators of protease activity: Implications in inflammation, complement activation, and atherothrombosis
Scott M. Gordon et al.
ATHEROSCLEROSIS (2017)
Global Burden of Stroke
Valery L. Feigin et al.
CIRCULATION RESEARCH (2017)
Proteomic analysis of HDL from inbred mouse strains implicates APOE associated with HDL in reduced cholesterol efflux capacity via the ABCA1 pathway
Nathalie Pamir et al.
JOURNAL OF LIPID RESEARCH (2016)
Targeted Proteomics Identifies Paraoxonase/Arylesterase 1 (PON1) and Apolipoprotein Cs as Potential Risk Factors for Hypoalphalipoproteinemia in Diabetic Subjects Treated with Fenofibrate and Rosiglitazone
Graziella E. Ronsein et al.
MOLECULAR & CELLULAR PROTEOMICS (2016)
Dysfunctional HDL and atherosclerotic cardiovascular disease
Robert S. Rosenson et al.
NATURE REVIEWS CARDIOLOGY (2016)
Dysfunctional HDL in acute stroke
Guadalupe Ortiz-Munoz et al.
ATHEROSCLEROSIS (2016)
Proteome profiles of HDL particles of patients with chronic heart failure are associated with immune response and also include bacteria proteins
Andreas Oberbach et al.
CLINICA CHIMICA ACTA (2016)
Serum amyloid A impairs the antiinflammatory properties of HDL (vol 126, pg 796, 2016)
Chang Yeop Han et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Machine-learning approach identifies a pattern of gene expression in peripheral blood that can accurately detect ischaemic stroke
Grant C. O'Connell et al.
NPJ GENOMIC MEDICINE (2016)
HDL cholesterol and stroke risk: The Multi-Ethnic Study of Atherosclerosis
Samantha A. Reina et al.
ATHEROSCLEROSIS (2015)
Inflammatory remodeling of the HDL proteome impairs cholesterol efflux capacity
Tomas Vaisar et al.
JOURNAL OF LIPID RESEARCH (2015)
Parallel reaction monitoring (PRM) and selected reaction monitoring (SRM) exhibit comparable linearity, dynamic range and precision for targeted quantitative HDL proteomics
Graziella E. Ronsein et al.
JOURNAL OF PROTEOMICS (2015)
Association of HDL cholesterol efflux capacity with incident coronary heart disease events: a prospective case-control study
Danish Saleheen et al.
LANCET DIABETES & ENDOCRINOLOGY (2015)
The Japan Statin Treatment Against Recurrent Stroke (J-STARS): A Multicenter, Randomized, Open-label, Parallel-group Study
Naohisa Hosomi et al.
EBIOMEDICINE (2015)
Cholesterol, inflammation and innate immunity
Alan R. Tall et al.
NATURE REVIEWS IMMUNOLOGY (2015)
High-Density Lipoprotein and Atherosclerosis Regression Evidence From Preclinical and Clinical Studies
Jonathan E. Feig et al.
CIRCULATION RESEARCH (2014)
HDL Cholesterol Efflux Capacity and Incident Cardiovascular Events
Anand Rohatgi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Paradoxical Association of Enhanced Cholesterol Efflux With Increased Incident Cardiovascular Risks
Xin-Min Li et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2013)
Altered Activation of Endothelial Anti- and Proapoptotic Pathways by High-Density Lipoprotein from Patients with Coronary Artery Disease Role of High-Density Lipoprotein-Proteome Remodeling
Meliana Riwanto et al.
CIRCULATION (2013)
Multi-dimensional Co-separation Analysis Reveals Protein-Protein Interactions Defining Plasma Lipoprotein Subspecies
Scott M. Gordon et al.
MOLECULAR & CELLULAR PROTEOMICS (2013)
High-Density Lipoprotein Function, Dysfunction, and Reverse Cholesterol Transport
Edward A. Fisher et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
Cholesterol Efflux and Atheroprotection Advancing the Concept of Reverse Cholesterol Transport
Robert S. Rosenson et al.
CIRCULATION (2012)
Serum Amyloid A in Uremic HDL Promotes Inflammation
Thomas Weichhart et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
A new era for quantifying HDL and cardiovascular risk?
Jay W. Heinecke
NATURE MEDICINE (2012)
Lipid and Lipoprotein Biomarkers and the Risk of Ischemic Stroke in Postmenopausal Women
Jeffrey S. Berger et al.
STROKE (2012)
The role of HDL in innate immunity
Kenneth R. Feingold et al.
JOURNAL OF LIPID RESEARCH (2011)
HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms
Mohamad Navab et al.
NATURE REVIEWS CARDIOLOGY (2011)
Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis
Amit V. Khera et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
The Ability to Promote Efflux Via ABCA1 Determines the Capacity of Serum Specimens With Similar High-Density Lipoprotein Cholesterol to Remove Cholesterol From Macrophages
Margarita de la Llera-Moya et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
Executive Summary: Heart Disease and Stroke Statistics-2010 Update A Report From the American Heart Association
Donald Lloyd-Jones et al.
CIRCULATION (2010)
The acute phase response inhibits reverse cholesterol transport
Kenneth R. Feingold et al.
JOURNAL OF LIPID RESEARCH (2010)
Proteomic Characterization of Human Plasma High Density Lipoprotein Fractionated by Gel Filtration Chromatography
Scott M. Gordon et al.
JOURNAL OF PROTEOME RESEARCH (2010)
Lipid Profile Components and Risk of Ischemic Stroke
Joshua Z. Willey et al.
ARCHIVES OF NEUROLOGY (2009)
Proteomic Analysis of Defined HDL Subpopulations Reveals Particle-Specific Protein Clusters Relevance to Antioxidative Function
W. Sean Davidson et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
Inter-α-trypsin inhibitor heavy chain 4 is a novel marker of acute ischemic stroke
Rajpal S. Kashyap et al.
CLINICA CHIMICA ACTA (2009)
The role of reverse cholesterol transport in animals and humans and relationship to atherosclerosis
Daniel J. Rader et al.
JOURNAL OF LIPID RESEARCH (2009)
High-density lipoprotein-cholesterol and risk of stroke and carotid atherosclerosis: A systematic review
Pierre Amarenco et al.
ATHEROSCLEROSIS (2008)
Combined statin and niacin therapy remodels the high-density lipoprotein proteome
Pattie S. Green et al.
CIRCULATION (2008)
Associations between high-density lipoprotein cholesterol and both stroke and coronary heart disease in the Asia Pacific region
Mark Woodward et al.
EUROPEAN HEART JOURNAL (2007)
Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL
Tomas Vaisar et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Optimizing cutoff scores for the Barthel Index and the modified Rankin Scale for defining outcome in acute stroke trials
M Uyttenboogaart et al.
STROKE (2005)
Evaluation of C-reactive protein measurement for assessing the risk and prognosis in ischemic stroke - A statement for health care professionals from the CRP pooling project members
M Di Napoli et al.
STROKE (2005)
Association of cholesterol with stroke risk varies in stroke subtypes and patient subgroups
DL Tirschwell et al.
NEUROLOGY (2004)
Antiinflammatory properties of HDL
PJ Barter et al.
CIRCULATION RESEARCH (2004)
Total and HDL cholesterol and risk of stroke. EUROSTROKE: a collaborative study among research centres in Europe
ML Bots et al.
JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH (2002)
分享论文
